Analyst firms · Morgan Stanley · CAH
Morgan Stanley CAH price target and rating history
Cardinal Health Inc. (CAH) · Health Care
Morgan Stanley rates Cardinal Health Inc. (CAH) Overweight with a $76 price target, as of its latest action on Aug 22, 2022. It has published 3 rating actions on CAH since December 2021, including 1 upgrade and 0 downgrades.
- Current rating
- Overweight
- Price target
- $76
- Median target, all firms
- Too few
- Actions on CAH
- 3
Morgan Stanley price target on CAH
Every Morgan Stanley rating on CAH
- Aug 22, 2022
- Apr 12, 2022
- Dec 17, 2021
How other firms rate CAH
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| RBC Capital Markets | Outperform | $276 | Aug 19, 2026 |
| William Blair | Outperform | Apr 28, 2026 | |
| Citigroup | Buy | Jan 9, 2026 | |
| Barclays | Overweight | $243 | Dec 9, 2025 |
Questions about Morgan Stanley and CAH
- What is Morgan Stanley's price target for CAH?
- Morgan Stanley's latest stated price target for Cardinal Health Inc. (CAH) is $76, from its action on Aug 22, 2022.
- What is Morgan Stanley's rating on CAH?
- Morgan Stanley rates CAH Overweight, a bullish rating, as of Aug 22, 2022.
- When did Morgan Stanley last change its view on CAH?
- On Aug 22, 2022, Morgan Stanley resumes coverage at Overweight, price target $70 to $76.
More CAH rating histories
All Morgan Stanley ratingsCAH news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.